If your Medicare Advantage plan in Georgia makes you wait for pre-approval before it will pay for an MRI, a skilled nursing stay, or a specialist procedure, the rules changed in your favor. Since January 1, 2024, your plan has had to use Original Medicare's coverage criteria for basic benefits and keep an approved course of treatment authorized for as long as it is medically necessary. And since January 1, 2026, the Centers for Medicare and Medicaid Services (CMS) has given plans seven calendar days to decide a standard prior authorization request and 72 hours to decide an urgent one. One carve-out matters more than the rest, because it is the prior authorization families hit most: those decision deadlines cover medical services, not drugs. The CMS Interoperability and Prior Authorization Final Rule does not apply to prior authorization decisions for drugs at all. A prescription your plan is sitting on runs on the Part D coverage-determination track instead, where an expedited request must be decided within 24 hours.

Those protections matter to a lot of people here. Georgia is a heavy Medicare Advantage state: as of March 2026, more than half of Georgia's people with Medicare were enrolled in Medicare Advantage and other health plans, 1,132,433 of 2,025,688 by CMS's count. For those enrollees, prior authorization is the single most common friction point between a doctor's order and getting care, and the CMS reforms rewrote how that friction works.

The changes come from two federal rules. The Medicare Advantage and Part D Final Rule for Contract Year 2024 (CMS-4201-F) requires plans to use Original Medicare coverage criteria for basic benefits (42 CFR 422.101(b)), bars a plan from reversing an approval for lack of medical necessity (42 CFR 422.138), keeps an approved course of treatment authorized for as long as medically necessary, and makes plans publish any internal criteria they use. The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) set the seven-day and 72-hour deadlines and public metric reporting, which generally began January 1, 2026; the electronic (FHIR-based) prior authorization systems generally begin January 1, 2027.

This guide explains what each protection means for a Georgia Medicare Advantage enrollee, the ordered steps to take when a prior authorization is denied, the five-level appeals process, how the rules apply to dual-eligible Georgians in D-SNPs, and worked examples for common Georgia scenarios.

How Georgia Medicare prior authorization rules work

Georgia Medicare Advantage prior authorization is a utilization management tool that Medicare Advantage (Part C) and Medicare Part D plans use to require pre-approval before the plan will pay for certain services or drugs. The legal basis sits in Section 1852 of the Social Security Act, which authorizes Medicare Advantage plans to manage covered benefits through reasonable utilization controls, and in 42 CFR Part 422, which governs MA plan operations. Plans use prior authorization to confirm that a requested service is medically necessary, is covered under the plan's benefit design, and meets appropriate clinical criteria. In principle this steers care toward evidence-based treatment; in practice, prior authorization in Medicare Advantage became a flashpoint for disputes between beneficiaries, providers, and plans throughout the 2010s and early 2020s.

The key contrast for any Georgian weighing Original Medicare against Medicare Advantage: Original Medicare (Parts A and B) does not require prior authorization for most covered services. Medicare's own booklet puts it plainly: in most cases you don't need approval for Original Medicare to cover your services or items. The main mandatory exceptions are certain medical equipment and supplies on CMS's Required Prior Authorization List (power mobility devices and pressure reducing support surfaces among them) and a defined set of hospital outpatient department procedures; for repetitive, scheduled non-emergent ambulance transport, prior authorization is voluntary. Medicare Advantage, by contrast, relies heavily on prior authorization. A typical MA plan may require it for non-emergency hospital admissions, skilled nursing facility admissions, home health care, durable medical equipment over a dollar threshold, diagnostic imaging (MRI, CT, and PET scans), high-cost outpatient procedures, specialty drugs administered under Part B, and certain Part D specialty drugs.

The Center for Medicare and Medicaid Innovation, congressional committees, and the HHS Office of Inspector General have all studied Medicare Advantage prior authorization over the past several years. OIG's findings set the base rate first: Medicare Advantage plans approve the vast majority of requests, but they issue millions of denials each year, and some of those denials are for care that meets Medicare coverage rules.

What to do if your Georgia Medicare Advantage prior authorization is denied

If your plan denies a prior authorization, you have concrete rights and a short clock. Work these steps in order.

1
Step 1

Read the denial notice and find the exact reason

Plans must state the specific basis for a denial. If it says "not medically necessary," your appeal must show medical necessity; if it says "service not covered" or "alternative available," aim your evidence at that. The reason is where your appeal starts.

2
Step 2

Ask the plan for its clinical criteria

A plan may use its own internal criteria only where Medicare's criteria are not fully established, and it must make those criteria publicly accessible with the evidence and rationale behind them. If the plan applied criteria stricter than Original Medicare's on a basic benefit, say so in your appeal and cite 42 CFR 422.101(b).

3
Step 3

File a Level 1 appeal within 65 days

You have 65 days from the date on the plan's denial notice to request a plan reconsideration, and a late request must give a reason. An expedited plan decision is generally issued within 72 hours.

4
Step 4

Request an expedited appeal if your health is at risk

If waiting for the standard timeline could seriously jeopardize your health or ability to regain function, ask for a fast appeal, which is generally decided within 72 hours. Say clearly that the request is urgent and why.

5
Step 5

Call GeorgiaCares for free help

GeorgiaCares (SHIP) counselors can review your notice, explain your rights, and help you file at no cost: 1-866-552-4464 (option 4).

The OIG findings that drove reform

In April 2022, the HHS Office of Inspector General released report OEI-09-18-00260, titled "Some Medicare Advantage Organization Denials of Prior Authorization Requests Raise Concerns About Beneficiary Access to Medically Necessary Care." The OIG drew a stratified random sample of denials issued in June 2019 by 15 of the largest Medicare Advantage organizations, including 250 prior authorization denials. Among the prior authorization requests those plans denied, 13 percent met Medicare coverage rules, meaning the services likely would have been approved under Original Medicare. Among the payment requests they denied, 18 percent met both Medicare coverage rules and the plan's own billing rules. For the prior authorization denials that met the rules, OIG found two common causes: plan clinical criteria not contained in Medicare coverage rules, and requests for more documentation when the records already in hand were sufficient. Most of the wrongful payment denials came from human error in manual claims review and from system processing errors. OIG named advanced imaging such as MRIs and post-acute stays such as inpatient rehabilitation among the services wrongly denied. At the time, OIG said CMS guidance was not detailed enough to say whether plans could deny care on internal criteria beyond Medicare's rules, and it recommended new guidance; OIG now lists that recommendation as implemented, and since 2024 plans have had to make any internal criteria publicly accessible.

An earlier OIG report, OEI-09-16-00410 (2018), looked at what happened when denials were challenged: during 2014 through 2016, Medicare Advantage organizations overturned 75 percent of their own preauthorization and payment denials that beneficiaries and providers appealed, about 216,000 denials a year. Yet beneficiaries and providers appealed only 1 percent of denials to that first level, so most of that reversible care was never contested. The practical lesson for a Georgian holding a denial letter is the plainest one on this page: appeal.

The same 2018 report found that in 2015 CMS cited 56 percent of audited contracts for making inappropriate denials and 45 percent for sending denial letters with incomplete or incorrect information, which can make a successful appeal harder to file.

The 2024 CMS final rule on Medicare Advantage and Part D (88 Fed. Reg. 22120)

CMS published the Medicare Advantage and Part D Contract Year 2024 Final Rule on April 12, 2023, at 88 Fed. Reg. 22120. The rule took effect January 1, 2024. It contained several major reforms to Medicare Advantage prior authorization.

The first major reform was coverage criteria standardization. Under the CY2024 rule (CMS-4201-F), a Medicare Advantage plan must use Traditional (Original) Medicare coverage criteria when it makes a medical-necessity decision on a basic benefit, complying with national coverage determinations, local coverage decisions, and the general coverage rules in Traditional Medicare (42 CFR 422.101(b)). A plan may apply its own internal criteria only where Medicare criteria are "not fully established," which the regulation limits to three cases: general provisions need interpreting or supplementing (and the plan must show the added criteria's clinical benefits are highly likely to outweigh the harms, including from delayed care), a coverage determination explicitly allows coverage beyond its listed indications, or no Medicare rule sets criteria at all. Any internal criteria must be publicly accessible with a summary of the evidence, its sources, and the rationale (42 CFR 422.101(b)(6)). The prior authorization approval-finality rule is codified at 42 CFR 422.138: once a plan approves an item or service, it cannot later deny coverage for lack of medical necessity or reopen that decision except for good cause or evidence of fraud. The practical effect: when a plan decides whether a skilled nursing facility admission is medically necessary, it must apply Original Medicare's criteria, which include a qualifying inpatient hospital stay of at least three consecutive days, rather than a stricter threshold of its own.

The second major reform was continuity of care, under 42 CFR 422.112(b)(8), which covers basic benefits in coordinated care plans such as HMOs and PPOs. For an enrollee in an active course of treatment, an approved prior authorization "must be valid for as long as medically necessary to avoid disruptions in care," in line with the coverage criteria, the patient's medical history, and the treating provider's recommendation. And when someone enrolls in a plan after starting a course of treatment, whether new to the plan or new to Medicare, the plan must give at least a 90-day transition period, even if an out-of-network provider is furnishing the care, during which it must not disrupt or require reauthorization for that treatment. These protections matter most for chronic disease management, cancer treatment, long-term physical therapy, and ongoing skilled nursing care.

The third major reform was criteria transparency. A plan that uses internal coverage criteria must make them publicly accessible, along with the evidence summary, sources, and rationale behind them, so a clinician can see what evidence to submit and an enrollee contesting a denial can see the reasoning.

The CMS Interoperability and Prior Authorization Final Rule (89 Fed. Reg. 8758)

CMS published the Interoperability and Prior Authorization Final Rule on February 8, 2024, at 89 Fed. Reg. 8758. It applies not only to Medicare Advantage but also to Medicaid, the Children's Health Insurance Program, and qualified health plans on the Federally Facilitated Exchanges, and it sets the standard decision deadline at seven calendar days and the expedited deadline at 72 hours. Those two decision timeframes are the one piece that does not reach every payer the rule covers: qualified health plan issuers on the Federally Facilitated Exchanges are excluded from them.

The second limit is larger, and it decides whether this rule helps you at all: none of its policies apply to prior authorization decisions for drugs. CMS says so plainly in the rule's own denial-reason provision, that as with all policies in the final rule, it does not apply to prior authorization decisions for drugs, and drug prior authorizations are left out of the Patient Access API data as well. Prescriptions are the prior authorization most Medicare beneficiaries actually run into, so this is not a technicality. If your Medicare Advantage plan is holding up an expensive drug, counting down a 72-hour deadline that does not apply to your request can cost days on a cancer or cardiac prescription. Ask the plan for an expedited coverage determination on the drug side instead: it must decide a fast request within 24 hours, and a standard request within 72 hours of receiving it. Those are outer limits, and if the plan misses one, the silence counts as a denial and the plan must send your request to the Independent Review Entity within 24 hours.

The rule also requires impacted payers to post certain prior authorization metrics on their websites every year, so beneficiaries and their advocates can compare how plans perform.

The rule's requirements phase in across two compliance dates. The operational provisions generally begin January 1, 2026: impacted payers other than qualified health plan issuers on the Federally Facilitated Exchanges must decide expedited requests within 72 hours and standard requests within 7 calendar days, and impacted payers must give a specific reason for each denial and publicly report prior authorization metrics (the initial set due by March 31, 2026). The FHIR-based API requirements carry a separate, later date that generally begins January 1, 2027.

Georgia Medicare prior authorization rules: timelines before and after the reforms

Since January 1, 2026, a Medicare Advantage plan must decide a standard (non-urgent) prior authorization request for a medical item or service within seven calendar days and an expedited (urgent) one within 72 hours, and it must publicly report its prior authorization metrics. If you appeal, you have 65 days from the denial notice to file, and an expedited plan-level appeal is generally decided within 72 hours. Drug requests run on the Part D coverage-determination clock: 72 hours for a standard request and 24 hours for an expedited one.

What you are waiting on Deadline
Standard prior authorization decision (medical item or service) 7 calendar days
Expedited prior authorization decision (medical item or service) 72 hours
Standard Part D coverage determination (drug) 72 hours
Expedited Part D coverage determination (drug) 24 hours
Your deadline to file a Level 1 Part C appeal 65 days from the denial notice
Expedited plan-level appeal decision Generally 72 hours

The 5-level Medicare appeals process

When a Medicare Advantage plan denies prior authorization, the beneficiary has the right to appeal. The Medicare appeals process for MA coverage decisions has five levels.

Level 1 is plan reconsideration. The beneficiary asks the plan to reconsider its denial within 65 days of the date on the denial notice, giving a reason if the request is late. An expedited reconsideration is generally decided within 72 hours.

Level 2 is the Independent Review Entity (IRE). If the plan upholds the denial at Level 1, in whole or in part, the plan must automatically forward the case to the Part C IRE, an independent organization CMS contracts with. As of May 1, 2026, the CMS Part C IRE contractor is C2C Innovative Solutions, Inc.; MAXIMUS Federal Services was the prior contractor and processed requests received through April 30, 2026. If the plan dismisses your request instead of deciding it, nothing is forwarded automatically, but you can ask the IRE to review the dismissal within 65 calendar days of the dismissal notice. If the IRE rules against you, you have 60 days from its decision to ask for a Level 3 hearing.

Level 3 is an Administrative Law Judge (ALJ) hearing. If the IRE upholds the denial and the amount in controversy is at least $200 for calendar year 2026 (a threshold CMS adjusts annually for inflation), the beneficiary can request an ALJ hearing. ALJ hearings are conducted by the HHS Office of Medicare Hearings and Appeals. The beneficiary can present evidence, call witnesses, and have legal representation.

Level 4 is the Medicare Appeals Council. If the ALJ rules against the beneficiary, the beneficiary can request review by the Council, which sits within the HHS Departmental Appeals Board.

Level 5 is federal district court. If the Council rules against the beneficiary and the amount in controversy is at least $1,960 for calendar year 2026 (also adjusted annually by CMS), the beneficiary can file suit in federal district court.

Coverage criteria standardization in detail

The 2024 coverage-criteria rules are the foundation of the reforms. They require Medicare Advantage plans to use Original Medicare coverage criteria for basic Medicare-covered services, and the prior authorization approval-finality protection is codified at 42 CFR 422.138. Basic benefits are the Part A and Part B services Original Medicare covers; a Medicare Advantage plan must cover all of them that are medically necessary, except hospice, which Original Medicare continues to cover.

The implications are substantial. A plan cannot, for example, demand a longer hospital stay before covering skilled nursing facility care than Original Medicare's three consecutive inpatient days. Where Medicare's criteria are not fully established, a plan may use internal criteria only in the three cases the regulation lists, and it must publish them with the evidence and rationale behind them, never keep them proprietary or secret.

Continuity of care protections

Since 2024, approval of a prior authorization request for a course of treatment must be valid for as long as medically necessary to avoid disruptions in care, judged against the coverage criteria, the patient's medical history, and the treating provider's recommendation. That standard applies to basic benefits in coordinated care plans, and it changes the relationship between plan and beneficiary for ongoing care: an approval is tied to medical need, not to an arbitrary renewal date.

The protection also reaches people who change plans mid-treatment. If a beneficiary switches MA plans at Open Enrollment (October 15 through December 7) and the new plan year begins January 1, the new plan must provide at least a 90-day transition period for an active course of treatment, and during that period it must not disrupt or require reauthorization for that treatment. The same rule covers someone new to Medicare. This matters most for cancer patients, chronic disease patients, and others receiving extended courses of treatment.

Clinical criteria publication

When a plan uses its own internal coverage criteria for a medical-necessity decision, 42 CFR 422.101(b)(6)(ii) requires it to make public the criteria in use, a summary of the evidence it considered, a list of the sources of that evidence, and an explanation of why it adopted them. Providers can review them before requesting prior authorization and tailor their evidence to them; beneficiaries can review them after a denial to pinpoint the basis for an appeal. Publication also makes divergence from the federal floor visible, so advocates can spot plans whose criteria run stricter than Original Medicare.

Electronic prior authorization (e-PA) via FHIR APIs

The CMS Interoperability and Prior Authorization Final Rule also builds toward electronic prior authorization. Its FHIR (Fast Healthcare Interoperability Resources) application programming interface requirements, including the Prior Authorization API, generally begin January 1, 2027, a year after the decision deadlines. The aim is to replace today's phone-call, fax, and manual-entry workload with electronic submission and response.

Drug Price Negotiation Program interaction

Section 11401 of the Inflation Reduction Act of 2022 (Public Law 117-169) established the Medicare Drug Price Negotiation Program. The negotiated prices for the first 10 drugs took effect January 1, 2026.

The first 10 selected drugs are:

  • Eliquis (apixaban)
  • Jardiance (empagliflozin)
  • Xarelto (rivaroxaban)
  • Januvia (sitagliptin)
  • Farxiga (dapagliflozin)
  • Entresto (sacubitril/valsartan)
  • Enbrel (etanercept)
  • Imbruvica (ibrutinib)
  • Stelara (ustekinumab)
  • Fiasp / NovoLog (insulin aspart)

What the law guarantees is formulary access, not freedom from prior authorization: every Medicare drug plan, including Medicare Advantage plans with drug coverage, must include these drugs on its formulary, and CMS says it uses its formulary review to assess any practices that may undermine access to them. If your plan does put one of them behind prior authorization or step therapy, the request runs on the Part D coverage-determination clock: 24 hours for an expedited request, 72 hours for a standard one.

Georgia Medicare Advantage market landscape

More than half of Georgia's Medicare beneficiaries are in a Medicare Advantage plan. As of March 2026, CMS counted 1,132,433 of the state's 2,025,688 people with Medicare enrolled in Medicare Advantage and other health plans, with 893,255 in Original Medicare. For the 2026 plan year, CMS reports 180 Medicare Advantage plans available in Georgia, compared to 178 in 2025, and the average monthly MA premium changed from $13.76 in 2025 to $6.74 in 2026. That 180 is a statewide count, not the number of plans in front of any one shopper: a separate KFF analysis of the CMS landscape files, which counts only plans open to general enrollment and excludes Special Needs and employer plans, counts 102 such plans in Georgia and finds the average Georgia beneficiary chooses among 47 plans offered by an average of 8 insurers.

Plans come in several types (HMO, PPO, HMO-POS, Special Needs Plans), each with its own prior authorization rules. Beneficiaries selecting a plan should consult the plan's Evidence of Coverage and its Annual Notice of Change (ANOC), along with the plan's prior authorization list. The plan must disclose what services require prior authorization.

GeorgiaCares, Georgia's State Health Insurance Assistance Program (SHIP) administered by the Division of Aging Services under the Department of Human Services, provides free, unbiased counseling on Medicare Advantage selection and prior authorization disputes. GeorgiaCares counselors are available Monday through Friday, 8 a.m. to 5 p.m., at 1-866-552-4464 (option 4); the program is not affiliated with any insurance company, and its counselors do not sell insurance. Counselors can help beneficiaries understand their rights, file appeals, and identify when a denial appears to violate federal requirements.

For free legal help with a hard appeal, where you live decides where you call. The Georgia Legal Services Program provides free civil legal help in the 154 counties outside Metro Atlanta, but does not represent people living in Clayton, Cobb, DeKalb, Fulton, or Gwinnett counties; its statewide intake line is 1-833-457-7529, and 1-800-498-9469 is its published toll-free number. GLSP has other eligibility requirements and asks people to apply to find out whether they qualify. For people who live in Atlanta, Georgia's Office of State Administrative Hearings points to the Atlanta Legal Aid Society at (404) 524-5811.

Prior authorization for dual-eligible Georgians and D-SNPs

If you have both Medicare and full Georgia Medicaid, you are a dual eligible, and the prior authorization rules reach you in two layers. On the Medicare side, most dual eligibles who choose a Medicare Advantage plan enroll in a Dual Eligible Special Needs Plan (D-SNP), a Medicare Advantage plan built for people with both coverages. Which D-SNPs you can join depends on your county, because insurers decide where they do business, and the Georgia Department of Community Health placed a moratorium on contracting with any new D-SNPs starting August 1, 2025. A D-SNP is an HMO or PPO Medicare Advantage plan, so the prior authorization protections on this page apply to it: the seven-day and 72-hour deadlines, the Original Medicare coverage-criteria floor, and continuity of care.

Georgia's dual-eligible integration is looser than in states that run a single integrated Medicare-Medicaid plan. Georgia Medicaid delivers long-term services and supports at home through home- and community-based waivers, the Community Care Services Program (CCSP) and SOURCE, rather than through one integrated plan. That matters for prior authorization because a service your D-SNP denies under Medicare may still be covered on the Georgia Medicaid side, and vice versa, so a dual eligible often has two coverage paths and two appeal tracks. GeorgiaCares can help you sort out which program should authorize a given service before you appeal to the wrong one.

Worked example 1: Margaret 70 Atlanta MRI prior authorization

Margaret is a 70-year-old retiree living in Atlanta. She is enrolled in a Humana Medicare Advantage HMO plan. Margaret has been experiencing chronic lower back pain for the past six months. Her primary care physician at the Emory Healthcare network has tried conservative treatments (physical therapy, anti-inflammatory medications) without sufficient relief. The physician orders a lumbar spine MRI to evaluate for possible nerve compression or disc herniation.

Under the Humana plan, MRI imaging requires prior authorization. The physician's office submits the prior authorization request through Humana's provider portal. The request includes Margaret's clinical history, prior treatments, and clinical justification for the MRI.

Under the CMS deadlines in effect since January 1, 2026, Humana has 7 calendar days to respond to a standard prior authorization request. If Humana applies its own internal criteria to MRI requests, it must make them publicly accessible. The physician's office reviewed the criteria before submitting and confirmed that Margaret's case meets the criteria (chronic back pain not responsive to conservative treatment for at least 6 weeks, with clinical signs suggesting nerve involvement).

Humana approves the request within 5 days. Margaret has the MRI within 2 weeks of the order. The MRI shows mild disc bulge at L4-L5 without significant nerve compression. Margaret's physician recommends continued conservative management with addition of epidural steroid injections.

Because the criteria were public, the physician's office could prepare a stronger submission. Had Humana denied the MRI anyway, Margaret could have appealed within 65 days of the denial notice.

Worked example 2: Robert 75 Savannah SNF admission denial and appeal

Robert is a 75-year-old retiree living in Savannah. He is enrolled in a UnitedHealthcare Medicare Advantage PPO plan. Robert falls at home and fractures his right hip. He is admitted to Memorial Health University Medical Center in Savannah for hip replacement surgery. Following surgery, his orthopedic surgeon and case manager recommend admission to a skilled nursing facility (SNF) for rehabilitation.

UnitedHealthcare initially denies the SNF admission. The denial notice cites internal criteria stating that Robert can be discharged home with home health rehabilitation services rather than requiring inpatient SNF.

Robert's family contacts the discharge planning team and asks for an appeal. The team consults with GeorgiaCares (1-866-552-4464) and learns about the 2024 coverage-criteria standardization. Under Original Medicare coverage rules, Robert's case meets the criteria for SNF admission: he had a qualifying inpatient hospital stay of at least three consecutive days (time under observation would not have counted), he is entering a Medicare-certified SNF shortly after leaving the hospital, and he needs skilled services, here physical and occupational therapy, related to that stay.

The family files an expedited appeal at the plan level, which is generally decided within 72 hours. The plan-level reviewer reverses the denial. Robert is admitted to a SNF in Savannah for 20 days of inpatient rehabilitation.

Original Medicare covers SNF care for up to 100 days per benefit period: days 1 through 20 cost $0 a day once the $1,736 Part A deductible is paid (normally already paid for the hospital stay in the same benefit period), and days 21 through 100 carry a daily coinsurance of $217 in 2026. Under the continuity-of-care rule, the approval must stay valid for as long as Robert's skilled care is medically necessary. Robert receives 20 days of inpatient SNF care, makes good functional progress, and is discharged home with home health services.

Worked example 3: Patricia 65 Columbus negotiated Eliquis and the drug-side clock

Patricia is a 65-year-old new Medicare beneficiary living in Columbus. She enrolled in a Humana Medicare Advantage PPO plan with prescription drug coverage (MA-PD) effective her 65th birthday. Three months into her enrollment, Patricia is diagnosed with atrial fibrillation. Her cardiologist prescribes Eliquis (apixaban) for stroke prevention.

Eliquis is one of the first 10 drugs selected for the Medicare Drug Price Negotiation Program under Section 11401 of the Inflation Reduction Act of 2022. Effective January 1, 2026, Eliquis has a negotiated Maximum Fair Price of $231 for a 30-day supply, 56 percent below its 2023 list price of $521, and Humana must carry it on its formulary.

The negotiated price does not by itself take Eliquis out of the prior authorization rules, so Patricia's cardiologist checks Humana's formulary first. If a coverage determination is needed and waiting could seriously jeopardize Patricia's health, the cardiologist can ask for an expedited one; Humana must answer within 24 hours, or within 72 hours on a standard request. The interoperability rule's seven-day and 72-hour clocks do not apply, because it excludes prior authorization decisions for drugs.

Patricia's Part D cost-sharing for Eliquis depends on her plan's design, and her out-of-pocket spending is capped by the annual Part D out-of-pocket threshold that the Inflation Reduction Act put in place (the cap was $2,000 in 2025 and is $2,100 for 2026). Once her cumulative out-of-pocket spending on Eliquis and her other Part D drugs reaches $2,100 during 2026, she pays nothing for covered Part D drugs for the rest of the year.

Between the negotiated price, guaranteed formulary placement, the 24-hour expedited clock, and the annual Part D out-of-pocket cap, Patricia has real protection on a high-cost drug.

Worked example 4: Henry 72 Athens cancer continuity of care across plan switch

Henry is a 72-year-old retiree living in Athens. He is enrolled in an Aetna Medicare Advantage HMO plan in 2025. Henry was diagnosed with non-Hodgkin lymphoma in October 2025 and started a 6-month treatment regimen of rituximab combined with chemotherapy. Aetna approved the prior authorization for the full treatment course.

During the 2025 Open Enrollment Period (October 15 through December 7, 2025), Henry compared MA plans for 2026 and decided to switch to a UnitedHealthcare Medicare Advantage HMO plan effective January 1, 2026. The switch was motivated by lower premiums and a broader oncology network in the UnitedHealthcare plan.

Under the continuity-of-care rule, UnitedHealthcare must give Henry at least a 90-day transition period for his active course of treatment, and during that period it must not disrupt or require reauthorization for it, even if an out-of-network provider is treating him. That covers roughly January through March 2026.

Henry's course runs to about April, so his oncologist should file UnitedHealthcare's own prior authorization for the remaining weeks well before the transition period ends. Once UnitedHealthcare approves it, that approval must stay valid for as long as the treatment is medically necessary to avoid disruptions in care.

The transition period matters most for cancer patients, dialysis patients, transplant patients, and others on extended treatment regimens, for whom a gap in care at a plan switch can change outcomes.

Common mistakes Georgia beneficiaries make

A few avoidable mistakes trip up Georgia Medicare Advantage enrollees dealing with prior authorization:

  • Assuming Original Medicare works the same way. Original Medicare requires prior authorization only in narrow cases; most services need none. The difference is a key factor when weighing a switch between Original Medicare and Medicare Advantage.
  • Accepting a denial without reading the reason. Plans must state the specific basis, and that basis is where your appeal starts. "Not medically necessary" calls for medical-necessity evidence; "service not covered" calls for coverage evidence.
  • Missing the 65-day appeal deadline. You have 65 days from the date on the denial notice to file a Level 1 appeal, and a late request must give a reason.
  • Not requesting an expedited appeal when health is at risk. A fast appeal is generally decided within 72 hours; say the request is urgent and why.
  • Not asking for the plan's clinical criteria. If the plan applied criteria stricter than Original Medicare's to a basic benefit, raise 42 CFR 422.101(b) in your appeal.
  • Confusing prior authorization with referrals. HMO plans usually require referrals to specialists and PPOs usually do not, but either may require prior authorization regardless. The two are distinct.
  • Not calling GeorgiaCares. SHIP counselors help with appeals at no cost: 1-866-552-4464.
  • Delaying emergency care for pre-approval. Emergency care never requires prior authorization; get the care.
  • Assuming a negotiated drug skips prior authorization. The 10 selected drugs must be on every Medicare drug plan's formulary, but the negotiated price lowers the price, not the paperwork; check the formulary.
  • Treating silence as a yes. If the plan has not approved a request, you may owe the full cost, so get the decision in writing before you proceed.
  • Waiting out the 72 hours on a drug. The interoperability rule's decision deadlines do not apply to prior authorization decisions for drugs. Ask for an expedited coverage determination, which the plan must decide within 24 hours, rather than counting down a clock that does not run on your request.

FAQ

What is prior authorization in Medicare Advantage?

Prior authorization is a utilization management tool used by Medicare Advantage plans to require pre-approval before the plan will pay for certain services or drugs. Under Section 1852 of the Social Security Act and 42 CFR Part 422, plans may use prior authorization for non-emergency services. The plan reviews the request against its clinical criteria and either approves or denies.

What changed under the 2024 CMS final rule?

The Medicare Advantage and Part D Contract Year 2024 Final Rule (CMS-4201-F), effective January 1, 2024, restructured Medicare Advantage prior authorization. Its key reforms: (1) MA plans must use Original Medicare coverage criteria for basic benefits (42 CFR 422.101(b)); (2) an approval cannot later be reversed for lack of medical necessity (42 CFR 422.138); (3) an approved course of treatment stays authorized for as long as medically necessary, with a 90-day transition for new enrollees mid-treatment; (4) any internal criteria must be publicly accessible. The seven-day and 72-hour decision deadlines came later, from the interoperability rule, starting January 1, 2026.

What is 42 CFR 422.138?

42 CFR 422.138 is the regulation that limits prior authorization in Medicare Advantage. A coordinated care plan may use prior authorization only to confirm diagnoses or other medical criteria, to make sure a basic benefit is medically necessary, or to make sure a supplemental benefit is clinically appropriate, and once it approves an item or service it may not later deny coverage for lack of medical necessity except for good cause or reliable evidence of fraud. Together with 42 CFR 422.101, it requires plans to use Original Medicare coverage criteria for basic benefits; where those criteria are not fully established, a plan may use internal criteria only if it publishes them with the evidence and rationale behind them. The supplemental benefits in that sentence include the non-medical extras some plans offer chronically ill members, covered in our guide to Georgia Medicare SSBCI.

How long does a Medicare Advantage plan have to make a prior authorization decision?

Since January 1, 2026, plans have 7 calendar days to make a standard prior authorization decision and 72 hours to make an expedited (urgent) one. Those deadlines cover medical services, not drugs: the CMS Interoperability and Prior Authorization Final Rule does not apply to prior authorization decisions for drugs. A drug request runs on the coverage-determination clock instead, which is 24 hours for an expedited request and 72 hours for a standard one.

What is the difference between a standard and an expedited prior authorization request?

A standard prior authorization request is for a non-urgent service. The 7-day deadline applies. An expedited prior authorization request is for an urgent service where waiting for a standard decision would seriously jeopardize the beneficiary's health or ability to regain maximum function. The 72-hour deadline applies. The beneficiary or provider must indicate that the request is urgent and explain why.

What are continuity of care protections?

Since 2024, approval of a prior authorization for a course of treatment must be valid for as long as medically necessary to avoid disruptions in care, based on the coverage criteria, your medical history, and your treating provider's recommendation. This matters most for chronic disease management, cancer treatment, long-term physical therapy, and skilled nursing facility care.

Do continuity of care protections apply when I switch Medicare Advantage plans?

Partly. If you switch MA plans during Open Enrollment and your new plan year begins January 1, the new plan must give you at least a 90-day transition period for an active course of treatment, and during that period it must not disrupt or require reauthorization for it. If your treatment will run past those 90 days, have your doctor request the new plan's own authorization before the transition ends.

Do plans have to publish their clinical criteria?

If they use their own. A plan must apply Original Medicare's coverage criteria, which are already public; where it uses internal criteria, it must make them publicly accessible with a summary of the evidence, its sources, and the rationale. Providers can review the criteria before requesting prior authorization and submit evidence tailored to them.

What is the Medicare appeals process?

The Medicare appeals process has 5 levels: (1) plan reconsideration (Level 1); (2) Independent Review Entity (IRE) review (Level 2), handled by the CMS Part C IRE contractor (C2C Innovative Solutions as of May 1, 2026); (3) Administrative Law Judge (ALJ) hearing (Level 3); (4) Medicare Appeals Council (Level 4); (5) federal district court (Level 5). Appealing pays: OIG found that during 2014 to 2016 plans overturned 75 percent of the denials appealed to them at the first level, yet only 1 percent of denials were appealed.

How long do I have to appeal a denial?

For a Medicare Advantage plan, you have 65 days from the date on the plan's denial notice to file a Level 1 appeal (plan reconsideration), and a request filed late must give a reason.

What is the Independent Review Entity?

The Independent Review Entity (IRE) is a CMS contractor, independent of your plan, that reviews Medicare Advantage appeals afresh after the plan upholds a denial at Level 1. As of May 1, 2026, the Part C IRE contractor is C2C Innovative Solutions, Inc. (MAXIMUS Federal Services was the prior contractor for requests received through April 30, 2026). Your plan automatically forwards a denial it upholds, in whole or in part, to the IRE; if the IRE rules against you, you have 60 days to ask for a Level 3 hearing.

What is electronic prior authorization?

Electronic prior authorization (e-PA) uses FHIR (Fast Healthcare Interoperability Resources) APIs to allow automated submission, processing, and response of prior authorization requests. Under the CMS Interoperability and Prior Authorization Final Rule (89 Fed. Reg. 8758, February 8, 2024), the operational provisions (the decision timeframes, specific denial reasons, and public metrics reporting) generally begin January 1, 2026, and the FHIR-based API requirements generally begin January 1, 2027.

Do negotiated drugs require prior authorization?

The negotiation program does not by itself rule it out. What the law requires is that every Medicare drug plan include the 10 selected drugs with negotiated prices in effect since January 2026 (Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and the NovoLog/Fiasp insulins) on its formulary, and CMS reviews formularies for practices that may undermine access to them. If your plan requires prior authorization for one, an expedited coverage determination must be decided within 24 hours.

Does emergency care require prior authorization?

No. Emergency care does not require prior authorization. The plan must cover emergency care regardless of prior authorization status. Beneficiaries should obtain emergency care without delay.

What happens if the plan misses its deadline?

Don't treat silence as approval: if the plan has not approved a request, you may have to pay the full cost. For drugs, a missed coverage-determination deadline counts as a denial, and the plan must forward your request to the Independent Review Entity within 24 hours; ask the plan to confirm it did.

Can I get help with a prior authorization appeal?

Yes. GeorgiaCares (1-866-552-4464, option 4) is Georgia's State Health Insurance Assistance Program, and its counselors give free, unbiased help, including with filing Medicare appeals. National advocacy groups such as the Medicare Rights Center, the Center for Medicare Advocacy, and Justice in Aging also publish appeal guidance.

What are the OIG findings that drove the 2024 reforms?

The HHS Office of Inspector General report OEI-09-18-00260 (April 2022) sampled denials issued in June 2019 by 15 of the largest Medicare Advantage organizations and found that 13 percent of the denied prior authorization requests met Medicare coverage rules, meaning those services likely would have been approved under Original Medicare, and that 18 percent of the denied payment requests met Medicare coverage rules and the plan's own billing rules. An earlier OIG report, OEI-09-16-00410 (2018), found that plans overturned 75 percent of their own preauthorization and payment denials that were appealed during 2014 through 2016, about 216,000 denials a year, though only 1 percent of denials were appealed at all.

What services typically require prior authorization in Medicare Advantage?

Services that typically require prior authorization include non-emergency hospital admissions, skilled nursing facility admissions, home health care, durable medical equipment over a dollar threshold, diagnostic imaging (MRI, CT, PET scans), outpatient procedures with high cost, specialty drugs administered under Part B, and certain Part D specialty drugs. The specific list varies by plan; the plan must disclose it in the Evidence of Coverage and on the plan's website.

Where to get help with a Georgia prior authorization dispute

GeorgiaCares (Georgia SHIP) Free, unbiased Medicare counseling and hands-on help filing prior authorization appeals. 1-866-552-4464 aging.georgia.gov/georgia-ship
1-800-MEDICARE Answered 24 hours a day, 7 days a week, except some federal holidays. For a plan-specific problem, call your plan first; call here if the plan could not resolve it. 1-800-633-4227 (TTY 1-877-486-2048)https://www.medicare.gov/talk-to-someone medicare.gov
Medicare Rights Center National nonprofit with guidance on Medicare Advantage appeals and denials. medicarerights.org
Georgia Office of Insurance Commissioner Consumer-protection complaints about insurers operating in Georgia. oci.georgia.gov

Learn More

Your next step If your Medicare Advantage plan just denied a prior authorization, call GeorgiaCares (Georgia SHIP) at 1-866-552-4464 (option 4) for free help reading the denial and filing your Level 1 appeal within the 65-day window.

Find personalized help navigating Georgia Medicare prior authorization at brevy.com.


The information on Brevy.com is for educational purposes only and is not a substitute for professional legal, financial, or medical advice. Rules vary by state and program and change frequently. Always verify with the relevant agency or a qualified professional. Brevy is not a law firm, financial advisor, or healthcare provider.

Still have questions?

Brevy answers from this guide and every other guide here, and can check what you qualify for.

BC

Brevy Care Team

Expert eldercare guidance from Brevy's team of healthcare professionals and researchers.